SYBX SYNLOGIC, INC.

BEARISH Impact: 7/10 25-NSE
Horizon immediate Filed May 18, 2026 Processed 5d 11h ago SEC 0001354457-26-000470
Notable filing: 25-NSE

Price Chart

Loading chart...

Executive Summary

Nasdaq has finalized the delisting of Synlogic, Inc. (SYBX) common stock, effective May 28, 2026, following a withdrawal of the company's appeal and a January 2026 suspension. The stock has already been trading OTC since its suspension on January 21, 2026, making this 25-NSE filing a formal deregistration step with limited incremental trading impact.

Actionable Insight

The delisting is already priced in as the stock has been suspended and trading OTC since January 21, 2026. This 25-NSE finalizes the deregistration process with the SEC. Traders should watch for any subsequent steps such as a potential voluntary deregistration under Section 12(g) or going-private transaction, which would further reduce liquidity and transparency.

Key Facts

  • Nasdaq Staff determined Synlogic no longer qualified for listing under Listing Rule 5101, with initial notification on November 21, 2025.
  • Synlogic withdrew its appeal on January 16, 2026, and the Panel's decision to suspend the stock from the Exchange took effect on January 21, 2026.
  • Delisting becomes final at the opening of trading on May 28, 2026 — formal removal from Nasdaq registration.
  • Stock has been trading OTC since January 21, 2026 suspension; this filing is the final deregistration step.

Financial Impact

Complete loss of Nasdaq listing and registration for SYBX common stock; no transaction value or financial details provided in the filing.

liquiditymarket_accesstrading_venue

Risk Factors

  • Further reduced liquidity and institutional ownership as the stock is removed from all national exchange trading.
  • Potential risk of a going-private transaction or additional deregistration, eliminating public reporting obligations and further limiting shareholder exit options.
  • Possible downward re-rating as the company loses Nasdaq qualification, which may affect any remaining analyst coverage or investor interest.

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
0% bullish (6 analysts)

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
25-NSE Filing (Primary)0001354457-26-000470
Document: 0001354457-26-000470-index-headers.html0001354457-26-000470
Document: 0001354457-26-000470-index.html0001354457-26-000470
Document: 0001354457-26-000470.txt0001354457-26-000470
2 reports for SYBX
Performance horizon
Filters
Rows
Reports for SYBX — sortable, filterable
Type Now
May 18, 2026
5d ago
25-NSE
BEARISH ★ 7/10
$0.6600 awaiting T+20awaiting T+20$0.6600 (−0.00%)
Apr 30, 2026
23d ago
10-K/A
NEUTRAL ★ 2/10
awaiting T+20
Showing 2 of 2

US Market Status

Market Closed — Opens Tue (35h 15m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access